nach oben

Critical Care

Erschienen in:

01.08.2013 | Review

Clinical review: Glucose control in severely burned patients - current best practice

verfasst von: Marc G Jeschke

Erschienen in: Critical Care | Ausgabe 4/2013

Einloggen, um Zugang zu erhalten

Abstract

Tight glucose control changed the way many burn centers practice burn ICU care. However, after the initial impressive data, various clinical trials followed that showed mixed results. The objective of the present review is to discuss recent studies in the area of burn and critical care, and to identify the current best practice for current burn care providers. We reviewed relevant publications from PubMed and selected high-impact publications on tight glycemic control in various patient populations with a focus on burn patients. We conclude that in burns there seems to be a signal that insulin administration to a target range of 130 to 150 mg/dl is beneficial in terms of morbidity and mortality without the risk of hypoglycemia.

Nur mit Berechtigung zugänglich

Bringham PA, McLoughlin E: Burn incidence and medical care use in the United States: estimates, trends and data sources. J Burn Care Rehabil. 1996, 17: 95-107. 10.1097/00004630-199603000-00003.CrossRef

World Health Organization: A Graphical Overview of the Global Burden of Injuries. The Injury Chart Book. 2002, Geneva: WHO, 29:

Herndon DN, Tompkins RG: Support of the metabolic response to burn injury. Lancet. 2004, 363: 1895-1902. 10.1016/S0140-6736(04)16360-5.PubMedCrossRef

Jeschke MG, Chinkes DL, Finnerty CC, Kulp G, Suman OE, Norbury WB, Branski LK, Gauglitz GG, Mlcak RP, Herndon DN: Pathophysiologic response to severe burn injury. Ann Surg. 2008, 248: 387-401.PubMedPubMedCentralCrossRef

Wolfe RR, Durkot MJ, Allsop JR, Burke JF: Glucose metabolism in severely burned patients. Metabolism. 1979, 28: 1031-1039. 10.1016/0026-0495(79)90007-6.PubMedCrossRef

Wolfe RR, Herndon DN, Peters EJ, Jahoor F, Desai MH, Holland OB: Regulation of lipolysis in severely burned children. Ann Surg. 1987, 206: 214-221. 10.1097/00000658-198708000-00016.PubMedPubMedCentralCrossRef

Wolfe RR, Jahoor F, Hartl WH: Protein and amino acid metabolism after injury. Diabetes Metab Rev. 1989, 5: 149-164. 10.1002/dmr.5610050205.PubMedCrossRef

Wolfe RR, Miller HI, Spitzer JJ: Glucose and lactate kinetics in burn shock. Am J Physiol. 1977, 232: E415-E418.PubMed

Wilmore DW: Hormonal responses and their effect on metabolism. Surg Clin North Am. 1976, 56: 999-1018.PubMed

10.

Wilmore DW, Aulick LH: Metabolic changes in burned patients. Surg Clin North Am. 1978, 58: 1173-1187.PubMed

11.

Gore DC, Chinkes D, Heggers J, Herndon DN, Wolf SE, Desai M: Association of hyperglycemia with increased mortality after severe burn injury. J Trauma. 2001, 51: 540-544. 10.1097/00005373-200109000-00021.PubMedCrossRef

12.

Gore DC, Chinkes DL, Hart DW, Wolf SE, Herndon DN, Sanford AP: Hyperglycemia exacerbates muscle protein catabolism in burn-injured patients. Crit Care Med. 2002, 30: 2438-2442. 10.1097/00003246-200211000-00006.PubMedCrossRef

13.

Hemmila MR, Taddonio MA, Arbabi S, Maggio PM, Wahl WL: Intensive insulin therapy is associated with reduced infectious complications in burn patients. Surgery. 2008, 144: 629-635. 10.1016/j.surg.2008.07.001.PubMedPubMedCentralCrossRef

14.

Jeschke MG, Kulp GA, Kraft R, Finnerty CC, Mlcak R, Lee JO, Herndon DN: Intensive insulin therapy in severely burned pediatric patients: a prospective randomized trial. Am J Respir Crit Care Med. 2010, 182: 351-359. 10.1164/rccm.201002-0190OC.PubMedPubMedCentralCrossRef

15.

Gore DC, Ferrando A, Barnett J, Wolf SE, Desai M, Herndon DN, Goodwin C, Wolfe RR: Influence of glucose kinetics on plasma lactate concentration and energy expenditure in severely burned patients. J Trauma. 2000, 49: 673-678. 10.1097/00005373-200010000-00015.PubMedCrossRef

16.

Van den Berghe G: Increased mortality associated with growth hormone treatment in critically ill adults. N Engl J Med. 2000, 342: 135-author reply 135-136PubMed

17.

Van den Berghe G: Insulin therapy for the critically ill patient. Clin Cornerstone. 2003, 5: 56-63. 10.1016/S1098-3597(03)90018-4.PubMedCrossRef

18.

Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med. 2006, 354: 449-461. 10.1056/NEJMoa052521.PubMedCrossRef

19.

van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001, 345: 1359-1367. 10.1056/NEJMoa011300.PubMedCrossRef

20.

Van den Berghe GH: Role of intravenous insulin therapy in critically ill patients. Endocr Pract. 2004, 10 (Suppl 2): 17-20.PubMedCrossRef

21.

Ellger B, Debaveye Y, Vanhorebeek I, Langouche L, Giulietti A, Van Etten E, Herijgers P, Mathieu C, Van den Berghe G: Survival benefits of intensive insulin therapy in critical illness: impact of maintaining normoglycemia versus glycemia-independent actions of insulin. Diabetes. 2006, 55: 1096-1105. 10.2337/diabetes.55.04.06.db05-1434.PubMedCrossRef

22.

Ingels C, Debaveye Y, Milants I, Buelens E, Peeraer A, Devriendt Y, Vanhoutte T, Van Damme A, Schetz M, Wouters PJ, Van den Berghe G: Strict blood glucose control with insulin during intensive care after cardiac surgery: impact on 4-years survival, dependency on medical care, and quality-of-life. Eur Heart J. 2006, 27: 2716-2724. 10.1093/eurheartj/ehi855.PubMedCrossRef

23.

Mesotten D, Gielen M, Sterken C, Claessens K, Hermans G, Vlasselaers D, Lemiere J, Lagae L, Gewillig M, Eyskens B, Vanhorebeek I, Wouters PJ, Van den Berghe G: Neurocognitive development of children 4 years after critical illness and treatment with tight glucose control: a randomized controlled trial. JAMA. 2012, 308: 1641-1650. 10.1001/jama.2012.12424.PubMedCrossRef

24.

Finney SJ, Zekveld C, Elia A, Evans TW: Glucose control and mortality in critically ill patients. JAMA. 2003, 290: 2041-2047. 10.1001/jama.290.15.2041.PubMedCrossRef

25.

Preiser JC, Devos P: Clinical experience with tight glucose control by intensive insulin therapy. Crit Care Med. 2007, 35: S503-S507. 10.1097/01.CCM.0000278046.24345.C7.PubMedCrossRef

26.

Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K: Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med. 2008, 358: 125-139. 10.1056/NEJMoa070716.PubMedCrossRef

27.

Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hebert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ: Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009, 360: 1283-1297.PubMedCrossRef

28.

Preiser JC, Devos P, Ruiz-Santana S, Melot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chiolero R: A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med. 2009, 35: 1738-1748. 10.1007/s00134-009-1585-2.PubMedCrossRef

29.

Agus MS, Steil GM, Wypij D, Costello JM, Laussen PC, Langer M, Alexander JL, Scoppettuolo LA, Pigula FA, Charpie JR, Ohye RG, Gaies MG: Tight glycemic control versus standard care after pediatric cardiac surgery. N Engl J Med. 2012, 367: 1208-1219. 10.1056/NEJMoa1206044.PubMedPubMedCentralCrossRef

30.

Hermayer KL, Egidi MF, Finch NJ, Baliga P, Lin A, Kettinger L, Biggins S, Carter RE: A randomized controlled trial to evaluate the effect of glycemic control on renal transplantation outcomes. J Clin Endocrinol Metab. 2012, 97: 4399-4406. 10.1210/jc.2012-1979.PubMedCrossRef

31.

Egi M, Bellomo R, Stachowski E, French CJ, Hart GK, Taori G, Hegarty C, Bailey M: Hypoglycemia and outcome in critically ill patients. Mayo Clin Proc. 2010, 85: 217-224. 10.4065/mcp.2009.0394.PubMedPubMedCentralCrossRef

32.

Finfer S, Liu B, Chittock DR, Norton R, Myburgh JA, McArthur C, Mitchell I, Foster D, Dhingra V, Henderson WR, Ronco JJ, Bellomo R, Cook D, McDonald E, Dodek P, Hebert PC, Heyland DK, Robinson BG: Hypoglycemia and risk of death in critically ill patients. N Engl J Med. 2012, 367: 1108-1118.PubMedCrossRef

33.

Andel D, Kamolz LP: Blood glucose control in critically ill patients. Minerva Anestesiol. 2012, 78: 975-976.PubMed

34.

Schultz MJ, Harmsen RE, Korevaar JC, Abu-Hanna A, Van Braam Houckgeest F, Van Der Sluijs JP, Spronk PE: Adoption and implementation of the original strict glycemic control guideline is feasible and safe in adult critically ill patients. Minerva Anestesiol. 2012, 78: 982-995.PubMed

35.

Jeschke MG, Klein D, Thasler WE, Bolder U, Schlitt HJ, Jauch KW, Weiss TS: Insulin decreases inflammatory signal transcription factor expression in primary human liver cells after LPS challenge. Mol Med. 2008, 14: 11-19. 10.1007/s00894-007-0240-5.PubMedPubMedCentralCrossRef

36.

Pham TN, Warren AJ, Phan HH, Molitor F, Greenhalgh DG, Palmieri TL: Impact of tight glycemic control in severely burned children. J Trauma. 2005, 59: 1148-1154.PubMedCrossRef

37.

Zhang K, Kaufman RJ: From endoplasmic-reticulum stress to the inflammatory response. Nature. 2008, 454: 455-462. 10.1038/nature07203.PubMedPubMedCentralCrossRef

38.

Jeschke MG, Finnerty CC, Herndon DN, Song J, Boehning D, Tompkins RG, Baker HV, Gauglitz GG: Severe injury is associated with insulin resistance, endoplasmic reticulum stress response, and unfolded protein response. Ann Surg. 2012, 255: 370-378. 10.1097/SLA.0b013e31823e76e7.PubMedPubMedCentralCrossRef

39.

Allison SP, Hinton P, Chamberlain MJ: Intravenous glucose-tolerance, insulin, and free-fatty-acid levels in burned patients. Lancet. 1968, 2: 1113-1116.PubMedCrossRef

40.

Hinton P, Allison SP: Insulin and glucose to reduce catabolic response to burns. Lancet. 1971, 1: 1247-PubMedCrossRef

41.

Wilmore DW, Long JM, Mason AD, Skreen RW, Pruitt BA: Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg. 1974, 180: 653-669. 10.1097/00000658-197410000-00031.PubMedPubMedCentralCrossRef

42.

Ferrando AA, Chinkes DL, Wolf SE, Matin S, Herndon DN, Wolfe RR: A submaximal dose of insulin promotes net skeletal muscle protein synthesis in patients with severe burns. Ann Surg. 1999, 229: 11-18. 10.1097/00000658-199901000-00002.PubMedPubMedCentralCrossRef

43.

Pierre EJ, Barrow RE, Hawkins HK, Nguyen TT, Sakurai Y, Desai M, Wolfe RR, Herndon DN: Effects of insulin on wound healing. J Trauma. 1998, 44: 342-345. 10.1097/00005373-199802000-00019.PubMedCrossRef

44.

Thomas SJ, Morimoto K, Herndon DN, Ferrando AA, Wolfe RR, Klein D, Wolf SE: The effect of prolonged euglycemic hyperinsulinemia on lean body mass after severe burn. Surgery. 2002, 132: 341-347. 10.1067/msy.2002.126871.PubMedCrossRef

45.

Zhang XJ, Chinkes DL, Wolf SE, Wolfe RR: Insulin but not growth hormone stimulates protein anabolism in skin would and muscle. Am J Physiol. 1999, 276: E712-E720.PubMed

46.

Gauglitz GG, Toliver-Kinsky TE, Williams FN, Song J, Cui W, Herndon DN, Jeschke MG: Insulin increases resistance to burn wound infection-associated sepsis. Crit Care Med. 2010, 38: 202-208. 10.1097/CCM.0b013e3181b43236.PubMedCrossRef

47.

Cochran A, Davis L, Morris SE, Saffle JR: Safety and efficacy of an intensive insulin protocol in a burn-trauma intensive care unit. J Burn Care Res. 2008, 29: 187-191.PubMed

48.

Mann EA, Pidcoke HF, Salinas J, Holcomb JB, Wolf SE, Wade CE: The impact of intensive insulin protocols and restrictive blood transfusion strategies on glucose measurement in American Burn Association (ABA) verified burn centers. J Burn Care Res. 2008, 29: 718-723. 10.1097/BCR.0b013e3181848c74.PubMedCrossRef

49.

Gibson BR, Galiatsatos P, Rabiee A, Eaton L, Abu-Hamdah R, Christmas C, Milner SM, Andersen DK, Elahi D: Intensive insulin therapy confers a similar survival benefit in the burn intensive care unit to the surgical intensive care unit. Surgery. 2009, 146: 922-930. 10.1016/j.surg.2009.04.035.PubMedCrossRef

50.

Gauglitz GG, Herndon DN, Kulp GA, Meyer WJ, Jeschke MG: Abnormal insulin sensitivity persists up to three years in pediatric patients postburn. J Clin Endocrinol Metab. 2009, 94: 1656-1664. 10.1210/jc.2008-1947.PubMedPubMedCentralCrossRef

51.

Pierre E, Barrow RE, Sakurai Y, Wolfe RR, Herndon DN: Structural effects of insulin on wound healing. Plastic Surg. 1996, 36: 743-745.

52.

Tuvdendorj D, Zhang XJ, Chinkes DL, Aarsland A, Kulp GA, Jeschke MG, Herndon DN: Intensive insulin treatment increases donor site wound protein synthesis in burn patients. Surgery. 2011, 149: 512-518. 10.1016/j.surg.2010.10.021.PubMedPubMedCentralCrossRef

53.

Zhang XJ, Chinkes DL, Irtun O, Wolfe RR: Anabolic action of insulin on skin wound protein is augmented by exogenous amino acids. Am J Physiol Endocrinol Metab. 2002, 282: E1308-E1315.PubMedCrossRef

54.

Zhang XJ, Chinkes DL, Wu Z, Martini WZ, Wolfe RR: Fractional synthesis rates of DNA and protein in rabbit skin are not correlated. J Nutr. 2004, 134: 2401-2406.PubMed

55.

Jeschke MG, Klein D, Bolder U, Einspanier R: Insulin attenuates the systemic inflammatory response in endotoxemic rats. Endocrinology. 2004, 145: 4084-4093. 10.1210/en.2004-0592.PubMedCrossRef

56.

Jeschke MG, Klein D, Herndon DN: Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg. 2004, 239: 553-560. 10.1097/01.sla.0000118569.10289.ad.PubMedPubMedCentralCrossRef

57.

Jeschke MG, Rensing H, Klein D, Schubert T, Mautes AE, Bolder U, Croner RS: Insulin prevents liver damage and preserves liver function in lipopolysaccharide-induced endotoxemic rats. J Hepatol. 2005, 42: 870-879. 10.1016/j.jhep.2004.12.036.PubMedCrossRef

58.

Klein D, Schubert T, Horch RE, Jauch KW, Jeschke MG: Insulin treatment improves hepatic morphology and function through modulation of hepatic signals after severe trauma. Ann Surg. 2004, 240: 340-349. 10.1097/01.sla.0000133353.57674.cd.PubMedPubMedCentralCrossRef

59.

Aarsland A, Chinkes D, Wolfe RR: Contributions of de novo synthesis of fatty acids to total VLDL-triglyceride secretion during prolonged hyperglycemia/hyperinsulinemia in normal man. J Clin Invest. 1996, 98: 2008-2017. 10.1172/JCI119005.PubMedPubMedCentralCrossRef

60.

Jeschke MG, Kraft R, Song J, Gauglitz GG, Cox RA, Brooks NC, Finnerty CC, Kulp GA, Herndon DN, Boehning D: Insulin protects against hepatic damage postburn. Mol Med. 2011, 17: 516-522.PubMedPubMedCentralCrossRef

61.

Gauglitz GG, Halder S, Boehning DF, Kulp GA, Herndon DN, Barral JM, Jeschke MG: Post-burn hepatic insulin resistance is associated with endoplasmic reticulum (ER) stress. Shock. 2010, 33: 299-305. 10.1097/SHK.0b013e3181b2f439.PubMedCrossRef

62.

Cree MG, Aarsland A, Herndon DN, Wolfe RR: Role of fat metabolism in burn trauma-induced skeletal muscle insulin resistance. Crit Care Med. 2007, 35: S476-S483. 10.1097/01.CCM.0000278066.05354.53.PubMedCrossRef

63.

Cree MG, Fram RY, Herndon DN, Qian T, Angel C, Green JM, Mlcak R, Aarsland A, Wolfe RR: Human mitochondrial oxidative capacity is acutely impaired after burn trauma. Am J Surg. 2008, 196: 234-239. 10.1016/j.amjsurg.2007.09.048.PubMedPubMedCentralCrossRef

64.

Cree MG, Zwetsloot JJ, Herndon DN, Newcomer BR, Fram RY, Angel C, Green JM, Dohm GL, Sun D, Aarsland A, Wolfe RR: Insulin sensitivity is related to fat oxidation and protein kinase C activity in children with acute burn injury. J Burn Care Res. 2008, 29: 585-594. 10.1097/BCR.0b013e31817db88f.PubMedPubMedCentralCrossRef

65.

Jeschke MG, Boehning D: Endoplasmic reticulum stress and insulin resistance post-trauma: similarities to type 2 diabetes. J Cell Mol Med. 2012, 16: 437-444. 10.1111/j.1582-4934.2011.01405.x.PubMedPubMedCentralCrossRef

66.

Jeschke MG, Kraft R, Emdad F, Kulp GA, Williams FN, Herndon DN: Glucose control in severely thermally injured pediatric patients: what glucose range should be the target?. Ann Surg. 2010, 252: 521-528.PubMed

67.

Dellinger RP, Levy MM, Carlet JM, Bion J, Parker MM, Jaeschke R, Reinhart K, Angus DC, Brun-Buisson C, Beale R, Calandra T, Dhainaut JF, Gerlach H, Harvey M, Marini JJ, Marshall J, Ranieri M, Ramsay G, Sevransky J, Thompson BT, Townsend S, Vender JS, Zimmerman JL, Vincent JL: Surviving Sepsis Campaign: international guidelines for management of severe sepsis and septic shock: 2008. Crit Care Med. 2008, 36: 296-327. 10.1097/01.CCM.0000298158.12101.41.PubMedCrossRef

68.

Dellinger RP, Levy MM, Rhodes A, Annane D, Gerlach H, Opal SM, Sevransky JE, Sprung CL, Douglas IS, Jaeschke R, Osborn TM, Nunnally ME, Townsend SR, Reinhart K, Kleinpell RM, Angus DC, Deutschman CS, Machado FR, Rubenfeld GD, Webb SA, Beale RJ, Vincent JL, Moreno R: Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Crit Care Med. 2013, 41: 580-637. 10.1097/CCM.0b013e31827e83af.PubMedCrossRef

69.

Langouche L, Vanhorebeek I, Van den Berghe G: Therapy insight: the effect of tight glycemic control in acute illness. Nat Clin Pract Endocrinol Metab. 2007, 3: 270-278. 10.1038/ncpendmet0426.PubMedCrossRef

70.

Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: insulin dose versus glycemic control. Crit Care Med. 2003, 31: 359-366. 10.1097/01.CCM.0000045568.12881.10.PubMedCrossRef

71.

Vlasselaers D, Milants I, Desmet L, Wouters PJ, Vanhorebeek I, van den Heuvel I, Mesotten D, Casaer MP, Meyfroidt G, Ingels C, Muller J, Van Cromphaut S, Schetz M, Van den Berghe G: Intensive insulin therapy for patients in paediatric intensive care: a prospective, randomised controlled study. Lancet. 2009, 373: 547-556. 10.1016/S0140-6736(09)60044-1.PubMedCrossRef

72.

Pidcoke HF, Wanek SM, Rohleder LS, Holcomb JB, Wolf SE, Wade CE: Glucose variability is associated with high mortality after severe burn. J Trauma. 2009, 67: 990-995. 10.1097/TA.0b013e3181baef4b.PubMedCrossRef

73.

Pisarchik AN, Pochepen ON, Pisarchyk LA: Increasing blood glucose variability is a precursor of sepsis and mortality in burned patients. PLoS One. 2012, 7: e46582-10.1371/journal.pone.0046582.PubMedPubMedCentralCrossRef

74.

Mann EA, Salinas J, Pidcoke HF, Wolf SE, Holcomb JB, Wade CE: Error rates resulting from anemia can be corrected in multiple commonly used point-of-care glucometers. J Trauma. 2008, 64: 15-21. 10.1097/TA.0b013e318160b9e4.PubMedCrossRef

75.

Pidcoke HF, Wade CE, Mann EA, Salinas J, Cohee BM, Holcomb JB, Wolf SE: Anemia causes hypoglycemia in intensive care unit patients due to error in single-channel glucometers: methods of reducing patient risk. Crit Care Med. 2010, 38: 471-476. 10.1097/CCM.0b013e3181bc826f.PubMedPubMedCentralCrossRef

76.

Damiano ER, El-Khatib FH, Zheng H, Nathan DM, Russell SJ: A comparative effectiveness analysis of three continuous glucose monitors. Diabetes Care. 2013, 36: 251-259. 10.2337/dc12-0070.PubMedPubMedCentralCrossRef

77.

Mecott GA, Herndon DN, Kulp GA, Brooks NC, Al-Mousawi AM, Kraft R, Rivero HG, Williams FN, Branski LK, Jeschke MG: The use of exenatide in severely burned pediatric patients. Crit Care. 2010, 14: R153-10.1186/cc9222.PubMedPubMedCentralCrossRef

78.

Gore DC, Herndon DN, Wolfe RR: Comparison of peripheral metabolic effects of insulin and metformin following severe burn injury. J Trauma. 2005, 59: 316-323. 10.1097/01.ta.0000180387.34057.5a.PubMedCrossRef

79.

Gore DC, Wolf SE, Herndon DN, Wolfe RR: Metformin blunts stress-induced hyperglycemia after thermal injury. J Trauma. 2003, 54: 555-561. 10.1097/01.TA.0000026990.32856.58.PubMedCrossRef

80.

Gore DC, Wolf SE, Sanford A, Herndon DN, Wolfe RR: Influence of metformin on glucose intolerance and muscle catabolism following severe burn injury. Ann Surg. 2005, 241: 334-342. 10.1097/01.sla.0000152013.23032.d1.PubMedPubMedCentralCrossRef

81.

Cree MG, Newcomer BR, Herndon DN, Qian T, Sun D, Morio B, Zwetsloot JJ, Dohm GL, Fram RY, Mlcak RP, Aarsland A, Wolfe RR: PPAR-alpha agonism improves whole body and muscle mitochondrial fat oxidation, but does not alter intracellular fat concentrations in burn trauma children in a randomized controlled trial. Nutr Metab (Lond). 2007, 4: 9-10.1186/1743-7075-4-9.CrossRef

82.

Elijah IE, Borsheim E, Maybauer DM, Finnerty CC, Herndon DN, Maybauer MO: Role of the PPAR-alpha agonist fenofibrate in severe pediatric burn. Burns. 2012, 38: 481-486. 10.1016/j.burns.2011.12.004.PubMedPubMedCentralCrossRef

Titel: Clinical review: Glucose control in severely burned patients - current best practice
verfasst von: Marc G Jeschke
Publikationsdatum: 01.08.2013
Verlag: BioMed Central
Erschienen in: Critical Care / Ausgabe 4/2013
Elektronische ISSN: 1364-8535
DOI: https://doi.org/10.1186/cc12678

Neu im Fachgebiet AINS

Mehr Frauen im OP – weniger postoperative Komplikationen

21.05.2024 Allgemeine Chirurgie Nachrichten

Ein Frauenanteil von mindestens einem Drittel im ärztlichen Op.-Team war in einer großen retrospektiven Studie aus Kanada mit einer signifikanten Reduktion der postoperativen Morbidität assoziiert.

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Delir bei kritisch Kranken – Antipsychotika versus Placebo

16.05.2024 Delir Nachrichten

Um die Langzeitfolgen eines Delirs bei kritisch Kranken zu mildern, wird vielerorts auf eine Akuttherapie mit Antipsychotika gesetzt. Eine US-amerikanische Forschungsgruppe äußert jetzt erhebliche Vorbehalte gegen dieses Vorgehen. Denn es gibt neue Daten zum Langzeiteffekt von Haloperidol bzw. Ziprasidon versus Placebo.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

hier abonnieren

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Clinical review: Glucose control in severely burned patients - current best practice

Abstract

Neu im Fachgebiet AINS

Mehr Frauen im OP – weniger postoperative Komplikationen

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Delir bei kritisch Kranken – Antipsychotika versus Placebo

Klinikreform soll zehntausende Menschenleben retten

Update AINS

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2013

Comparison of the predictive performance of the BIG, TRISS, and PS09 score in anadult trauma population derived from multiple international trauma registries

TIMP-1 gene polymorphism: are genetics able to predict outcome of septic patients?

Renal macro- and microcirculation autoregulatory capacity during early sepsis and norepinephrine infusion in rats

Noninvasive intracranial pressure estimation by orbital subarachnoid space measurement: the Beijing Intracranial and Intraocular Pressure (iCOP) study

Do we need to innovate in critical care practice?

A protocol for resuscitation of severe burn patients guided by transpulmonary thermodilution and lactate levels: a 3-year prospective cohort study

Neu im Fachgebiet AINS

Mehr Frauen im OP – weniger postoperative Komplikationen

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

Delir bei kritisch Kranken – Antipsychotika versus Placebo

Klinikreform soll zehntausende Menschenleben retten

Update AINS